Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Nov 2003

Schwartz Marc D, Kaufman Elizabeth, Peshkin Beth N, Isaacs Claudine, Hughes Chanita, DeMarco Tiffani, Finch Clinton, Lerman Caryn

Abstract excerpt

PURPOSE: Despite the widespread availability of genetic testing for BRCA1/BRCA2 mutations, little is known about the impact of testing on ovarian cancer prevention and screening. For mutation testing to effect cancer mortality, positive test results must be followed by appropriate behavior change. In this study, we prospectively examined the impact of BRCA1/2 testing on the utilization of prophylactic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Patient Acceptance of Health Care

Share to Ultrasonography

Source

Identifiers

PMID: 14581427
DOI: 10.1200/JCO.2003.01.088

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.PMID 14581427Read ↗

Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.Semantic proximity Read ↗

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.Semantic proximity Read ↗

Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal.Semantic proximity Read ↗

Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriers.Semantic proximity Read ↗

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.Semantic proximity Read ↗

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers.Semantic proximity Read ↗

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.Semantic proximity Read ↗

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Semantic proximity Read ↗

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.